2025 annual financial data
ProQR Therapeutics 2025 Operating margin
Direct answer
Operating margin was -275.91%.
Operating income was -42,154,897 EUR and net income was -40,519,110 EUR.
Operating cash flow was -50,707,480 EUR.
Get free ProQR Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 15,278,232 EUR
- Operating income
- -42,154,897 EUR
- Net income
- -40,519,110 EUR
- Operating cash flow
- -50,707,480 EUR